Screening in liver disease: Report of an AASLD Clinical Workshop

被引：37

作者：

Adams, PC

Arthur, MJ

Boyer, TD

DeLeve, LD

Di Bisceghe, AM

Hall, M

Levin, TR

Provenzale, D

Seeff, L

机构：

[1] London Hlth Sci Ctr, London, ON N6A 5A5, Canada

[2] Univ Southampton, Southampton, Hants, England

[3] Arizona Liver Res Inst, Tucson, AZ USA

[4] Univ So Calif, Los Angeles, CA USA

[5] St Louis Univ, Sch Med, St Louis, MO USA

[6] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA

[7] Kaiser Permanente Med Ctr, Walnut Creek, CA USA

[8] Duke Univ, Med Ctr, Durham, NC USA

[9] NIDDK, NIH, Bethesda, MD USA

来源：

HEPATOLOGY | 2004年 / 39卷 / 05期

关键词：

D O I：

10.1002/hep.20169

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

This report summarizes an AASLD Clinical Workshop that was presented at Digestive Diseases Week 2003 on screening in liver diseases. As newer diagnostic tests become available, many liver diseases and complications of liver disease can be detected at an early asymptomatic stage. In many cases, early detection can lead to earlier treatment and an improved outcome. However, screening for liver diseases in asymptomatic persons has the potential for adverse consequences, including discrimination and stigmatization. The cost of screening programs is significant, and access to screening tests varies in different countries. Future screening programs require careful planning and implementation to balance the benefits, risks, and cost-effectiveness. This review outlines the concepts of screening and their application to a broad range of liver diseases.

引用

页码：1204 / 1212

页数：9

共 54 条

[1]

Genotypic/phenotypic correlations in genetic hemochromatosis: Evolution of diagnostic criteria [J].